Lobbying Filing Details

Total Spending

$630,000

Activities

4

Lobbyists

3

Gov't Entities

12

Filing Information
Filing UUID:
299ed63b-d877-40f4-b7a8-cded40c5afcc
Type:
Q4 - 4th Quarter - Report
Period:
2021 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2022 at 3:18 PM
Income:
$0
Expenses:
$630,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Samantha Ventimiglia
Registrant
VERTEX PHARMACEUTICALS INCORPORATED

Global biotechnology company

Boston, Massachusetts
Client
VERTEX PHARMACEUTICALS INCORPORATED
Massachusetts, United States of America
Lobbying Activities (4)
Activity 1
Budget/Appropriations

Issues related to funding for the Food and Drug Administration (S 2599 and HR 4356: "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022.")

Lobbyists (1)
  • SCOTT BARNES
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
Activity 2
Health Issues

Issues related to access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); Issues related to FDA regulatory pathways for pharmaceuticals (no specific bills); Issues related to pharmaceutical pricing (HR 3, "Elijah E. Cummings Lower Drug Costs Now Act"; HR 19, "Lower Costs, More Cures Act"; S 2164, "Lower Costs, More Cures Act"); S Res 477, expressing support for the designation of September 2021 as "Sickle Cell Disease Awareness Month"; HR 6000, "Cures 2.0"; and, Issues related to health care and prescription drug pricing in HR 5376, "Build Back Better Act," and Senate companion legislation (no specific bill).

Lobbyists (3)
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
Activity 3
Medicare/Medicaid

Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills).

Lobbyists (3)
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
Activity 4
Taxation/Internal Revenue Code

Issues related to corporate and international tax policy and research and development tax credits (no specific bills). Issues related to the Orphan Drug Tax Credit. Issues related to corporate and international tax policy in HR 5376, "Build Back Better Act," and related provisions debated in Senate (no specific bill).

Lobbyists (3)
  • SCOTT BARNES
  • MATTHEW O SCHUMAKER
  • KWAMME ANDERSON
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.